MicroRNA 452 Regulates Cell Proliferation, Cell Migration, and Angiogenesis in Colorectal Cancer by Suppressing VEGFA...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Colorectal cancer (CRC) is a significant health concern with complex molecular underpinnings.
• MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
• The specific function of microRNA 452 (MIR452) in CRC remains largely unelucidated.

Purpose of the Study:

• To investigate the functional role and molecular mechanisms of MIR452 in colorectal cancer.
• To identify direct target genes of MIR452 involved in CRC pathogenesis.
• To explore the therapeutic potential of MIR452 in CRC treatment.

Main Methods:

• miRNA expression profiling of CRC tissues versus normal tissues.
• Bioinformatic prediction and experimental validation of MIR452 target genes.
• In vitro assays (cell culture, transfection) to assess VEGFA expression and signaling pathways.
• In vivo studies (xenografts in mice, aortic ring assay in rats) to evaluate MIR452's effect on proliferation and angiogenesis.

Main Results:

• MIR452 was significantly upregulated in human CRC tissues.
• Vascular endothelial growth factor A (VEGFA) was identified as a direct MIR452 target, with its expression downregulated by MIR452.
• MIR452 modulated VEGFA-mediated signaling pathways (VEGFR2-MAPK, VEGFR2-SRC).
• MIR452 suppressed tumor cell proliferation and angiogenesis in vivo and in vitro.

Conclusions:

• MIR452 acts as a tumor suppressor in early CRC progression by inhibiting VEGFA.
• MIR452 regulates key cancer hallmarks including cell proliferation and angiogenesis.
• MIR452 demonstrates potential as a therapeutic agent for colorectal cancer.